Atara Biotherapeutics, Inc. - Common Stock (ATRA)

CUSIP: 046513107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Stock
Shares outstanding
8,165,808
Total 13F shares
48,253,940
Share change
+1,902,979
Total reported value
$1,676,297,014
Put/Call ratio
30%
Price per share
$34.74
Number of holders
119
Value change
+$62,510,625
Number of buys
56
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
77%
6,254,632
$258,629,000 30 Sep 2018
13F
FMR LLC
13F
Company
63%
5,180,737
$214,224,000 30 Sep 2018
13F
Redmile Group, LLC
13F
Company
52%
4,218,717
$174,444,000 30 Sep 2018
13F
BlackRock Finance, Inc.
13F
Company
43%
3,490,782
$144,345,000 30 Sep 2018
13F
VANGUARD GROUP INC
13F
Company
30%
2,487,567
$102,861,000 30 Sep 2018
13F
BRIDGER MANAGEMENT, LLC
13F
Company
30%
2,459,253
$101,690,000 30 Sep 2018
13F
STATE STREET CORP
13F
Company
26%
2,105,716
$87,070,000 30 Sep 2018
13F
MORGAN STANLEY
13F
Company
23%
1,890,131
$78,157,000 30 Sep 2018
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
22%
1,766,845
$73,059,000 30 Sep 2018
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
20%
1,624,958
$67,192,000 30 Sep 2018
13F
Camber Capital Management LP
13F
Company
20%
1,620,000
$66,987,000 30 Sep 2018
13F
ArrowMark Colorado Holdings LLC
13F
Company
18%
1,502,811
$62,141,000 30 Sep 2018
13F
CARILLON TOWER ADVISERS, INC.
13F
Company
16%
1,286,445
$53,194,000 30 Sep 2018
13F
Neuberger Berman Group LLC
13F
Company
15%
1,218,539
$50,386,000 30 Sep 2018
13F
JPMORGAN CHASE & CO
13F
Company
15%
1,202,912
$49,741,000 30 Sep 2018
13F
Artal Group S.A.
13F
Company
12%
1,000,000
$41,350,000 30 Sep 2018
13F
NORTHERN TRUST CORP
13F
Company
6.4%
524,063
$21,670,000 30 Sep 2018
13F
FEDERATED HERMES, INC.
13F
Company
5.8%
475,400
$19,658,000 30 Sep 2018
13F
NORGES BANK
13F
Company
5.6%
461,093
$19,066,000 30 Sep 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
5.5%
451,532
$18,670,000 30 Sep 2018
13F
Assenagon Asset Management S.A.
13F
Company
5.1%
415,520
$17,182,000 30 Sep 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
5%
410,379
$16,969,000 30 Sep 2018
13F
PUTNAM INVESTMENTS LLC
13F
Company
3.3%
267,884
$11,077,000 30 Sep 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3%
242,062
$10,010,000 30 Sep 2018
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
3%
240,948
$9,963,000 30 Sep 2018
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2.8%
229,141
$9,474,000 30 Sep 2018
13F
HIGHLINE CAPITAL MANAGEMENT, L.P.
13F
Company
2.8%
227,400
$9,403,000 30 Sep 2018
13F
DEUTSCHE BANK AG\
13F
Company
2.7%
221,911
$9,175,000 30 Sep 2018
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
2.7%
217,418
$8,990,235 30 Sep 2018
13F
Bank of New York Mellon Corp
13F
Company
2.2%
179,505
$7,422,000 30 Sep 2018
13F
AMERIPRISE FINANCIAL INC
13F
Company
2.2%
178,159
$7,368,000 30 Sep 2018
13F
12 West Capital Management LP
13F
Company
1.9%
158,700
$6,562,000 30 Sep 2018
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.7%
141,615
$5,855,000 30 Sep 2018
13F
PACIFIC HEIGHTS ASSET MANAGEMENT LLC
13F
Company
1.5%
125,000
$5,169,000 30 Sep 2018
13F
TIVERTON ASSET MANAGEMENT LLC
13F
Company
1.3%
103,158
$4,265,000 30 Sep 2018
13F
Polar Capital LLP
13F
Company
1.2%
100,000
$4,135,000 30 Sep 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
1.1%
90,276
$3,734,000 30 Sep 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
1%
85,416
$3,532,000 30 Sep 2018
13F
CITIGROUP INC
13F
Company
1%
83,567
$3,455,000 30 Sep 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
1%
82,280
$3,402,000 30 Sep 2018
13F
ALPS ADVISORS INC
13F
Company
0.98%
80,238
$3,318,000 30 Sep 2018
13F
University Of Notre Dame du Lac
13F
Individual
0.88%
72,188
$2,985,000 30 Sep 2018
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.79%
64,173
$2,654,000 30 Sep 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.67%
54,640
$2,259,000 30 Sep 2018
13F
Swiss National Bank
13F
Company
0.64%
52,600
$2,175,000 30 Sep 2018
13F
Vident Investment Advisory, LLC
13F
Company
0.63%
51,500
$2,130,000 30 Sep 2018
13F
EATON VANCE MANAGEMENT
13F
Company
0.6%
48,806
$2,018,000 30 Sep 2018
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.59%
47,800
$1,977,000 30 Sep 2018
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.57%
46,366
$1,917,000 30 Sep 2018
13F
TD ASSET MANAGEMENT INC
13F
Company
0.56%
45,489
$1,881,000 30 Sep 2018
13F

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2018

As of 31 Dec 2018, Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by 119 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,253,940 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, BlackRock Inc., Vanguard Group Inc, BRIDGER MANAGEMENT, LLC, Camber Capital Management LP, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, and STATE STREET CORP. This page lists 119 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
114
Q4 2018 holders
119
Holder diff
5
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 Value $ Q4 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .